In vitro permeability of round window membrane to transforming dexamethasone with delivery vehicles - A dosage estimation

Chinese Medical Journal

Volumn 120, Issue 24, 2007, Pages 2284-2289

  Sun, Jian Jun ^a   Liu, Ya ^a,b   Kong, Wei Jia ^b   Jiang, Ping ^a   Jiang, Wei ^a  

^a NAVY GENERAL HOSPITAL   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Dexamethasone; High performance liquid chromatography; Pharmacokinetic; Round window membrane

Indexed keywords

ALGINIC ACID; CHITIN; DEXAMETHASONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIODEGRADABILITY; CELL MEMBRANE PERMEABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DATA ANALYSIS; DIFFUSION; DRUG PENETRATION; DRUG STABILITY; GEL; IN VITRO STUDY; NONHUMAN; REPRODUCIBILITY; SIMULATION; SUSTAINED RELEASE FORMULATION;

EID: 38349189162     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200712020-00025     Document Type: Article

References (28)

1. Shea JJ Jr, Ge X. Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Meniere's disease. Otolaryngol Clin North Am 1996; 29: 353-358.
2. Kanzaki J, Ouchi T, Tsuchihashi N. Steroid-responsive sensorineural hearing loss: combination therapy with prednisolone and Sairei-to. ORL J Otorhinolaryngol Relat Spec 1993; 55: 24-29.
3. Lamm K, Arnold W. The effect of prednisolone and non-steroidal anti-inflammatory agents on the normal and noise-damaged guinea pig inner ear. Hear Res 1998; 115: 149-161.
4. Niedermeyer HP, Zahneisen G, Luppa P, Busch R, Arnold W. Cortisol levels in the human perilymph after intravenous administration of prednisolone. Audiol Neurootol 2003; 8: 316-321.
5. Ye Q, Tillein J, Hartmann R, Gstoettner W, Kiefer J. Application of a corticosteroid (Triamcinolon) protects inner ear function after surgical intervention. Ear Hear 2007; 28: 361-369.
6. Jackson LE, Silverstein H. Chemical perfusion of the inner ear. Otolaryngol Clin North Am 2002; 35: 639-653.
7. Hoffer ME, Allen K, Kopke RD, Weisskopf P, Gottshall K, Wester D. Transtympanic versus sustained-release administration of gentamicin: kinetics, morphology, and function. Laryngoscope 2001; 111: 1343-1357.
8. Balough BJ, Hoffer ME, Wester D, O'Leary MJ, Brooker CR, Goto M. Kinetics of gentamicin uptake in the inner ear of Chinchilla langier after middle-ear administration in a sustained-release vehicle. Otolaryngol Head Neck Surg 1998; 119: 427-431.
9. Selivanova OA, Gouveris H, Victor A, Amedee RG, Mann W. Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss. Otol Neurotol 2005; 26: 890-895.
10. Sheppard WM, Wanamaker HH, Pack A, Yamamoto S, Slepecky N. Direct round window application of gentamicin with varying delivery vehicles: a comparison of ototoxicity. Otolaryngol Head Neck Surg 2004; 131: 890-896.
11. Chandrasekhar SS. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol 2001; 22: 18-23.
12. Tamura T, Kita T, Nakagawa T, Endo T, Kim TS, Ishihara T, et al. Drug delivery to the cochlea using PLGA nanoparticles. Laryngoscope 2005; 115: 2000-2005.
13. Barnes AL, Wassel RA, Mondalek F, Chen K, Dormer KJ, Kopke RD. Magnetic characterization of superparamagnetic nanoparticles pulled through model membranes. Biomagn Res Technol 2007; 4: 1.
14. Wee S, Gombotz WR. Protein release from alginate matrices. Advanced Drug Delivery Reviews 1998; 31: 267-285.
15. Kato Y, Onishi H, Machida Y. Application of chitin and chitosan derivatives in the pharmaceutical field. Curr Pharm Biotechnol 2003; 4: 303-309.
16. Liu Y, Sun JJ, Li XS, Jiang P. Histological effects of sodium alginate gel - the drug delivery vehicle on the bullea of guinea pigs. J Audiol Speech Pathol 2004; 12: 247-248.
17. Zhao WQ, Yin YG, Liang Q. Controlled released of salidroside from Chitosan-Alginate microcapusules. Food Fermentation Industries (Chin) 2004; 30: 66-69.
18. Witte MC, Kasperbauer JL. Round window membrane permeability to transforming growth factor-α: An in vitro study. Otolaryngol Head Neck Surgery 2000; 123 (1 Pt 1): 91-96.
19. Liu Y, Sun JJ, Kong WJ, Jiang W, Jiang P. Creating the in vitro experimental apparatus for round window membrane and the control of its quality. Acta Med Univ Sci Technol Huazhong 2006; 35: 250-252.
20. Goycoolea MV, Lundman L. Round window membrane. Structure function and permeability: a review. Microsc Res Tech 1997; 36: 201-211.
21. Liu Y, Jiang P, Sun JJ, Kong WJ. Quick preparing the sample of round window membrane and its observation using environmental scanning electron microscopy. J Clin Otorhinolaryngol 2005; 19: 902-904.
22. Hargunani CA, Kempton JB, DeGagne JM, Trune DR. Intratympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form. Otol Neurotol 2006; 27: 564-569.
23. Salt AN, Hale SA, Plonkte SK. Perilymph sampling from the cochlear apex: a reliable method to obtain higher purity perilymph samples from scala tympani. J Neurosci Methods 2006; 153: 121-129.
24. Rauch SD. Intratympanic steroids for sensorineural hearing loss. Otolaryngol Clin North Am 2004; 37: 1061-1074.
25. Seidman MD, Vivek P. Intratympanic treatment of hearing loss with novel and traditional agents. Otolaryngol Clin North Am 2004; 37: 973-990.
26. Lefebvre PP, Staecker H. Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study. Acta Otolaryngol 2002; 122: 698-702.
27. Kopke RD, Hoffer ME, Wester D, O'Leary MJ, Jackson RL. Targeted topical steroid therapy in sudden sensorineural hearing loss. Otol Neurotol 2001; 22: 475-479.
28. Salt AN, Ma Y. Quantification of solute entry into cochlear perilymph through the round window membrane. Hear Res 2001; 154: 88-97.